{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:58:09Z","timestamp":1769201889798,"version":"3.49.0"},"reference-count":52,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,5]]},"abstract":"<jats:p>Arachidonic acid (ARA), an omega-6 fatty acid, kills juvenile and adult schistosomes <jats:italic>in vitro<\/jats:italic> and displays highly significant and safe therapeutic effects in mice and hamsters infected with <jats:italic>Schistosoma mansoni<\/jats:italic> or <jats:italic>S. haematobium<\/jats:italic>. This study aims to examine the efficacy and safety of ARA in treatment of school-age children infected with <jats:italic>S. mansoni<\/jats:italic>. In total, 66 <jats:italic>S. mansoni<\/jats:italic>-infected schoolchildren (20\u201323 children\/study arm) received a single dose of 40 mg\/kg praziquantel (PZQ), ARA (10 mg\/kg per day for 15 days), or PZQ combined with ARA. The children were examined before and after treatment for worm egg counts in stool and blood biochemical and immunological parameters. ARA proved to be as efficacious as PZQ in treatment of schoolchildren with low infection intensity (78% and 85% cure rates, respectively). For moderate-intensity infection, the ARA and PZQ combination led to 100% cure rate. Biochemical, hematological, and immunological parameters were either unchanged or ameliorated after ARA therapy.<\/jats:p>","DOI":"10.4269\/ajtmh.14-0328","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T07:20:42Z","timestamp":1411456842000},"page":"973-981","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and Safety of Arachidonic Acid for Treatment of Schistosoma mansoni-Infected Children in Menoufiya, Egypt"],"prefix":"10.4269","volume":"91","author":[{"given":"Sahar","family":"Selim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"El Sagheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza","family":"El Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashida","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike J.","family":"Bruins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashika","family":"El Ridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Am J Trop Med Hyg","first-page":"54","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014"},{"key":"R2","series-title":"J Adv Res","first-page":"433","article-title":"Human schistosomiasis: clinical perspective: review","volume":"4","author":"Barsoum","year":"2013"},{"key":"R3","series-title":"J Adv Res","first-page":"445","article-title":"Hepatic and intestinal schistosomiasis: review","volume":"4","author":"El-Baz","year":"2013"},{"key":"R4","series-title":"J Adv Res","first-page":"453","article-title":"Urinary schistosomiasis: review","volume":"4","author":"Barsoum","year":"2013"},{"key":"R5","series-title":"PLoS Negl Trop Dis","first-page":"e1321","article-title":"Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review","volume":"5","author":"King","year":"2011"},{"key":"R6","series-title":"Trop Med Int Health","first-page":"450","article-title":"Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya","volume":"14","author":"Black","year":"2009"},{"key":"R7","series-title":"Parasitology","first-page":"440","article-title":"Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt","volume":"138","author":"Barakat","year":"2011"},{"key":"R8","series-title":"Asian Pac J Trop Biomed","first-page":"235","article-title":"Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, southern Ethiopia","volume":"2","author":"Erko","year":"2012"},{"key":"R9","series-title":"Int J Antimicrob Agents","first-page":"570","article-title":"Praziquantel binds Schistosoma mansoni adult worm actin","volume":"29","author":"Tallima","year":"2007"},{"key":"R10","series-title":"Antimicrob Agents Chemother","first-page":"1054","article-title":"Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni","volume":"53","author":"Gnanasekar","year":"2009"},{"key":"R11","series-title":"Parasitol Res","first-page":"1871","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"Wang","year":"2012"},{"key":"R12","series-title":"Antimicrob Agents Chemother","first-page":"1487","article-title":"Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials","volume":"47","author":"Utzinger","year":"2003"},{"key":"R13","series-title":"Trends Parasitol","first-page":"379","article-title":"Will new antischistosomal drugs finally emerge?","volume":"24","author":"Cioli","year":"2008"},{"key":"R14","series-title":"Parasitol Res","first-page":"955","article-title":"Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges","volume":"104","author":"Abdul-Ghani","year":"2009"},{"key":"R15","series-title":"J Adv Res","first-page":"467","article-title":"Novel therapeutic and prevention approaches for schistosomiasis: review","volume":"4","author":"El Ridi","year":"2013"},{"key":"R16","series-title":"Antimicrob Agents Chemother","first-page":"3383","article-title":"In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium","volume":"54","author":"El Ridi","year":"2010"},{"key":"R17","series-title":"Int J Antimicrob Agents","first-page":"232","article-title":"Arachidonic acid efficacy and mechanism of action in treatment of hamsters infected with Schistosoma mansoni or S. haematobium","volume":"39","author":"El Ridi","year":"2012"},{"key":"R18","series-title":"Mol Biochem Parasitol","first-page":"145","article-title":"Interconversion of sphingomyelin and ceramide in adult Schistosoma mansoni","volume":"90","author":"Redman","year":"1997"},{"key":"R19","series-title":"Immunology","first-page":"274","article-title":"Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids","volume":"91","author":"Robinson","year":"1997"},{"key":"R20","series-title":"J Parasitol","first-page":"730","article-title":"Equilibrium in lung schistosomula sphingomyelin breakdown and biosynthesis allows very small molecules, but not antibody, to access proteins at the host-parasite interface","volume":"92","author":"El Ridi","year":"2006"},{"key":"R21","series-title":"Mol Biochem Parasitol","first-page":"23","article-title":"Enzymatic activity and immunolocalization of Schistosoma mansoni and Schistosoma haematobium neutral sphingomyelinase","volume":"178","author":"Tallima","year":"2011"},{"key":"R22","series-title":"Cell Biochem Biophys","first-page":"359","article-title":"Is there a sphingomyelin-based hydrogen bond barrier at the mammalian host-schistosome parasite interface?","volume":"68","author":"Migliardo","year":"2014"},{"key":"R23","series-title":"J Clin Invest","first-page":"1339","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001"},{"key":"R24","series-title":"Prostaglandins Leukot Essent Fatty Acids","first-page":"141","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005"},{"key":"R25","series-title":"J Lipid Res","first-page":"1521","article-title":"Sources of eicosanoid precursor fatty acid pools in tissues","volume":"42","author":"Zhou","year":"2001"},{"key":"R26","series-title":"Lipids","first-page":"449","article-title":"Effects of dietary arachidonic acid on human immune response","volume":"32","author":"Kelley","year":"1997"},{"key":"R27","series-title":"Lipids","first-page":"125","article-title":"Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men","volume":"33","author":"Kelley","year":"1998"},{"key":"R28","series-title":"Lipids","first-page":"323","article-title":"Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3","volume":"38","author":"Harbige","year":"2003"},{"key":"R29","series-title":"Circulation","first-page":"902","article-title":"Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention","volume":"119","author":"Harris","year":"2009"},{"key":"R30","series-title":"J Int Soc Sports Nutr","first-page":"21","article-title":"Effects of arachidonic acid supplementation on training adaptations in resistance-trained males","volume":"4","author":"Roberts","year":"2007"},{"key":"R31","series-title":"Kisechugaku Zasshi","first-page":"35","article-title":"Comparative examinations of faecal thick smear techniques with cellophane paper covers","volume":"3","author":"Kato","year":"1954"},{"key":"R32","series-title":"Rev Inst Med Trop Sao Paulo","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni","volume":"14","author":"Katz","year":"1972"},{"key":"R33","series-title":"J Biol Chem","first-page":"497","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957"},{"key":"R34","series-title":"J Lipid Res","first-page":"600","article-title":"Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride\u2013methanol","volume":"5","author":"Morrison","year":"1964"},{"key":"R35","series-title":"Infect Immun","first-page":"237","article-title":"Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy","volume":"69","author":"El Ridi","year":"2001"},{"key":"R36","series-title":"PLoS Negl Trop Dis","first-page":"e350","article-title":"Mefloquine\u2014an aminoalcohol with promising antischistosomal properties in mice","volume":"3","author":"Keiser","year":"2009"},{"key":"R37","series-title":"Am J Trop Med Hyg","first-page":"112","article-title":"Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immuno-competent NMRI mice","volume":"82","author":"Keiser","year":"2010"},{"key":"R38","series-title":"Clin Infect Dis","first-page":"1205","article-title":"Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial","volume":"50","author":"Keiser","year":"2010"},{"key":"R39","series-title":"Antimicrob Agents Chemother","first-page":"4506","article-title":"Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection","volume":"57","author":"Ingram","year":"2013"},{"key":"R40","series-title":"Parasitol Res","first-page":"3723","article-title":"Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies","volume":"112","author":"Xiao","year":"2013"},{"key":"R41","series-title":"Am J Trop Med Hyg","first-page":"365","article-title":"Efficacy of myrrh in the treatment of human Schistosomiasis mansoni","volume":"73","author":"Barakat","year":"2005"},{"key":"R42","series-title":"Am J Trop Med Hyg","first-page":"119","article-title":"Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households","volume":"72","author":"Botros","year":"2005"},{"key":"R43","series-title":"East Mediterr Health J","first-page":"932","article-title":"Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans","volume":"16","author":"Osman","year":"2010"},{"key":"R44","series-title":"Trans R Soc Trop Med Hyg","first-page":"1062","article-title":"Artesunate plus sulfadoxine\/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan","volume":"103","author":"Mohamed","year":"2009"},{"key":"R45","series-title":"Parasitology","first-page":"1825","article-title":"Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs","volume":"136","author":"Doenhoff","year":"2009"},{"key":"R46","series-title":"Trop Med Int Health","first-page":"744","article-title":"What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections?","volume":"5","author":"De Clercq","year":"2000"},{"key":"R47","series-title":"J Helminthol","first-page":"132","article-title":"Schistosoma mansoni infection as a predictor of severe anaemia in schoolchildren in eastern Sudan","volume":"84","author":"Mahgoub","year":"2010"},{"key":"R48","series-title":"Am J Trop Med Hyg","first-page":"278","article-title":"Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy","volume":"75","author":"Koukounari","year":"2006"},{"key":"R49","series-title":"Antimicrob Agents Chemother","first-page":"2780","article-title":"Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni","volume":"52","author":"Martins-Leite","year":"2008"},{"key":"R50","series-title":"Circulation","first-page":"902","article-title":"Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention","volume":"119","author":"Harris","year":"2009"},{"key":"R51","series-title":"Infect Immun","first-page":"2051","article-title":"Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4","volume":"77","author":"Jiz","year":"2009"},{"key":"R52","series-title":"Infect Immun","first-page":"4264","article-title":"Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis?","volume":"80","author":"Fitzsimmons","year":"2012"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/91\/5\/article-p973.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/91\/5\/article-p973.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/91\/5\/article-p973.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T21:08:51Z","timestamp":1723064931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/91\/5\/article-p973.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":52,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.14-0328","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,5]]}}}